ClinicalTrialsFinder

Refractory Peripheral T-Cell Lymphoma Clinical Trials in Chengdu, Chengdu

1 recruitingChengdu, Chengdu, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma

Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
Haihe Biopharma Co., Ltd.100 enrolled1 locationNCT06909877